- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Chest x-rays find cancers along with false positives
Chest x-rays can detect early lung cancer in asymptomatic people but at the cost of many false positives, according to preliminary findings from the National Cancer Institute's Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. The study is the first major controlled trial to include women in its evaluation of lung cancer screening.
Chest x-rays can detect early lung cancer in asymptomatic people but at the cost of many false positives, according to preliminary findings from the National Cancer Institute's Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. The study is the first major controlled trial to include women in its evaluation of lung cancer screening.
Of the 67,038 men and women who received a baseline chest x-ray, 5991 (8.9%) were positive and required additional evaluation. Of the 5991 positive baseline screens, 126 (2.1%) were found to have cancer within 12 months.
Comparing the results of women and men, researchers found that the incidence of positive screens was lower among women (8.2%) than among men (9.6%). This trend was found in every age group (between 54 and 75 years), in current and former smokers, in those who never smoked, and in smokers with a history of fewer than 30 pack-years (smoking 20 cigarettes per day for 30 years) or of 30 or more pack-years.
The study appeared in the Dec. 21, 2005, issue of Journal of the National Cancer Institute.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
